The abstract is read at the publisher; the summary is JClub's.
ASCO Living Guidelines for multiple myeloma are continuously updated to reflect rapidly evolving evidence, with scheduled revisions by an expert panel.
- Why it matters: Rapidly changing research can make static recommendations quickly outdated, so clinicians need a living, systematically reviewed source to guide practice.
- What they did: A standing expert panel continuously reviews the health literature and updates recommendations on a regular schedule, following ASCO guideline methodology and conflict-of-interest policies.
- The result: The resulting living guideline updates are intended to inform clinical practice while not replacing clinician judgment or accounting for individual patient variation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.